POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to cut blood removal in rare cancer
Disease control Not yet recruitingThis trial tests rusfertide, an injected drug, in Japanese adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal is to see if rusfertide can keep red blood cell levels under control and reduce the need for phlebotomy (blood removal). Al…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New oral drug could tame overactive bone marrow in rare blood cancers
Disease control Not yet recruitingThis study tests a pill called selinexor in 15 adults with chronic blood cancers (MPN) whose blood cell counts are too high. The goal is to see if selinexor can safely bring those counts down and ease symptoms. Participants take the drug once a week for up to 3 months and are fol…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Personalized exercise shows promise for fatigue in rare blood cancers
Symptom relief Not yet recruitingThis study tests whether a 12-week personalized exercise program can reduce fatigue and improve physical function in people with myeloproliferative neoplasms (MPN) and chronic myeloid leukemia (CML). Participants will do supervised aerobic and resistance training twice a week plu…
Matched conditions: POLYCYTHEMIA VERA
Phase: NA • Sponsor: Carmen Fava • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC